Let’s start up with the current stock price of Bionano Genomics Inc. (BNGO), which is $0.51 to be very precise. The Stock rose vividly during the last session to $0.519 after opening rate of $0.51 while the lowest price it went was recorded $0.4925 before closing at $0.51.
Recently in News on December 15, 2020, Bionano’s Saphyr System Used to Characterize Virus Integration Into Human Genome. Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a paper in the Proceedings of the National Academy of Sciences (PNAS) that describes the detailed characterization of how and where the human herpesvirus 6 (HHV-6) integrates in the human genome of its hosts. The study, which involved an international collaboration of scientists from prestigious institutions including the Freie Universität Berlin and the Fred Hutchinson Cancer Research Center at the University of Washington, used optical genome mapping with Saphyr to determine precisely the location of the viral sequence in the human telomeres, a region of the genome that is known to be difficult to analyze by next-generation sequencing. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Bionano Genomics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.3200 on 01/02/20, with the lowest value was $0.2500 for the same time period, recorded on 04/02/20.
Bionano Genomics Inc. (BNGO) full year performance was -51.38%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Bionano Genomics Inc. shares are logging -63.31% during the 52-week period from high price, and 104.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.25 and $1.39.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4903448 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Bionano Genomics Inc. (BNGO) recorded performance in the market was -58.87%, having the revenues showcasing -19.05% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 77.79M, as it employees total of 97 workers.
Analysts verdict on Bionano Genomics Inc. (BNGO)
During the last month, 0 analysts gave the Bionano Genomics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.5914, with a change in the price was noted -0.3031. In a similar fashion, Bionano Genomics Inc. posted a movement of -37.28% for the period of last 100 days, recording 7,934,955 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BNGO is recording 1.09 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.12.
Bionano Genomics Inc. (BNGO): Technical Analysis
Raw Stochastic average of Bionano Genomics Inc. in the period of last 50 days is set at 22.41%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 44.78%. In the last 20 days, the company’s Stochastic %K was 40.63% and its Stochastic %D was recorded 31.91%.
Let’s take a glance in the erstwhile performances of Bionano Genomics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -58.87%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -2.04%, alongside a downfall of -51.38% for the period of the last 12 months. The shares increased approximately by 0.41% in the 7-day charts and went down by 1.13% in the period of the last 30 days. Common stock shares were lifted by -19.05% during last recorded quarter.